TAILIEUCHUNG - Framework for Program Evaluation in Public Health

This report, which is written for all who are concerned about the dangers posed by the harmful use of alcohol, can serve as a comprehensive knowledge base on the status of alcohol consumption, alcohol-related harm and alcohol policies in the world. Health ministries and other concerned parties can use it to support the development and implementation of their policies and interventions. Since 1974, WHO has been actively involved in documenting and reporting on alcohol- related health issues and problems. Indeed, this publication follows in the wake of the fi rst Global status report on alcohol in 1999 and the second. | cpc AND PREVENTION WEEKLY REPORT September 17 1999 Vol. 48 No. RR-11 Recommendations and Reports Inside Continuing Education Examination Framework for Program Evaluation in Public Health . DEPARTMENT OF HEALTH HUMAN SERVICES Centers for Disease Control and Prevention CDC Atlanta Georgia 30333 The MMWR series of publications is published by the Epidemiology Program Office Centers for Disease Control and Prevention CDC . Department of Health and Human Services Atlanta GA 30333. SUGGESTED CITATION Centers for Disease Control and Prevention. Framework for program evaluation in public health. MMWR 1999 48 No. RR-11 inclusive page numbers . Centers for Disease Control and P Koplan . . Director The production of this report as an MMWR serial publication was coordinated in Epidemiology Program Holloway . Acting Director Office of Scientific and Health Communications Recommendations and Reports. .John W. Ward . Director Editor MMWR Series .Suzanne M. Hewitt . Managing Editor C. Kay Smith-Akin . Project Editor Morie M. Higgins Peter M. Jenkins Visual Information Specialists Use of trade names and commercial sources is for identification only and does not imply endorsement by the . Department of Health and Human Services. References to sites of non-CDC organizations on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the . Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. Copies can be purchased from Superintendent of Documents . Government Printing Office Washington DC 20402-9325. Telephone 202 512-1800. Vol. 48 I No. RR-11 MMWR i Contents Procedures for Developing the Defining Key Integrating Evaluation with Routine Program Assigning Value To Program Framework

• Y học thường thức
• Clinical Pattern
• Diagnostics and Therapy
• Severe Cutaneous
• Mechanisms Regulating
• Atopic Dermatitis
• Diagnosing Vascular
• Multidrugresistant MRSA
• Prevalence of MRSA in clinical samples
• MRSA in clinical samples
• Antibiotic sensitivity pattern
• Antibiotic susceptibility pattern
• Prevalence of MRSA
• Clinical isolates of staphylococcus aureus
• Tertiary care hospital
• Prevalence of MRSA among clinical isolates
• Antibiotic susceptibility
• Clinical isolates
• Neonatal septicemia
• Clinical isolates of neonatal septicemia
• Antimicrobial sensitivity pattern
• Methicillin resistant staphylococcus aureus
• Methicillin resistant coagulase negative
• Staphylococcus isolated
• Various clinical samples
• Various clinical specimens
• Klebsiella species isolated
• Medical college and hospital
• Obtained by Kirby Bauer
• Pseudomonas aeruginosa
• Piperacillin Tazobactum
• Klebsiella pneumoniae
• ESBL producing Klebsiella pneumoniae
• Antimicrobial susceptibility pattern
• ESBL producing clinical isolates
• Appropriate infection control measures
• Multidrug resistance
• Methicillin resistant staphylococcus aureus isolated
• Various clinical specimen
• Tertiary care post graduate teaching institute
• Pseudomonas aeruginosa (P aeruginosa)
• Antimicrobial resistance pattern
• Government medical college
• Antimycotic susceptibility
• Chromogenic agar
• Conventional method
• Antimycotic susceptibility pattern
• Candida species isolated
• Enterococcal species
• Vancomycin resistance
• Infection control
• Clinical isolates of enterococci
• Nosocomial infection
• Gram negative non fermenting bacteria
• Resistant pattern
• Rural population in South India
• Adverse cutaneous drug reaction
• Maculopapular rash
• Toxic epidermal necrolysis
• Cutaneous drug reaction
• Antimicrobial susceptibility
• Vancomycin resistant enterococci
• Bacterial infection
• Susceptibility pattern
• Multi drug resistant
• Acinetobacter species among clinical isolates
• Susceptibility pattern of Acinetobacter species
• Incidence of Acinetobacter species
• Hospital can minimize its incidence
• Antibiotic sensitivity
• Antibiotic resistance
• High level aminoglycoside resistance
• Isolation of enterococcus
• Microbiological study
• Wound samples
• Staphylococcus aureus isolated
• Escherichia coli
• Dynamism in resistance pattern
• Drift from Indian council of medical
• Antimicrobial use guidelines
• Clinical specimens
• ESBL producers
• Resistance pattern
• Extended spectrum beta lactamase producers
• Klebsiella spp
• Clavulanic acid
• In vitro antimicrobial susceptibility pattern
• ESBL producing Escherichia coli
• Blood stream
• Bacteriological investigation
• Escherichia coli isolated
• Non Fermenting gram negative bacilli
• Pseudomonas aeurginosa
• Polymyxin B
• BMC Veterinary Research
• Equine metabolic syndrome
• Hyperinsulinaemia associated laminitis
• Insulin dysregulation
• Clinical cases
• Proteus species
• Biofilm production